UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 469

Sortiert nach

Dermatokinetics of Therapeutic Agents

Murthy, S. Narasimha

1, 2011

Volltextzugriff (PDF)

Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: metabolism and bioactivities relevant to human health

Marine Drugs, 2011-10, Vol.9 (10), p.1806-1828

2011

Volltextzugriff (PDF)

The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects

Trends in pharmacological sciences (Regular ed.), 2018-01, Vol.39 (1), p.1-12

2018

Volltextzugriff (PDF)

Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review

Journal of cellular physiology, 2019-02, Vol.234 (2), p.1165-1178

2019

Volltextzugriff (PDF)

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial

British journal of dermatology (1951), 2015-10, Vol.173 (4), p.930-939

2015

Volltextzugriff (PDF)

Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box–Behnken design, in-vitro evaluation and in-vivo skin deposition study

International journal of pharmaceutics, 2015-05, Vol.485 (1-2), p.235-243

2015

Volltextzugriff (PDF)

Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products

The AAPS journal, 2013-01, Vol.15 (1), p.41-52

2013

Volltextzugriff (PDF)

A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis

British journal of dermatology (1951), 2013-07, Vol.169 (1), p.137-145

2013

Volltextzugriff (PDF)

Study of vitamin E microencapsulation and controlled release from chitosan/sodium lauryl ether sulfate microcapsules

Carbohydrate polymers, 2021-01, Vol.251, p.116988, Article 116988

2021

Volltextzugriff (PDF)

Combination of argan oil and phospholipids for the development of an effective liposome-like formulation able to improve skin hydration and allantoin dermal delivery

International journal of pharmaceutics, 2016-05, Vol.505 (1-2), p.204-211

2016

Volltextzugriff (PDF)

Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents

Journal of dermatological science, 2021-06, Vol.102 (3), p.142-157

2021

Volltextzugriff (PDF)

Potential of Curcumin in Skin Disorders

Nutrients, 2019-09, Vol.11 (9), p.2169

2019

Volltextzugriff (PDF)

Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis

Journal of nanobiotechnology, 2020-05, Vol.18 (1), p.80-14, Article 80

2020

Volltextzugriff (PDF)

Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula

Journal of ethnopharmacology, 2016-08, Vol.190, p.272-287

2016

Volltextzugriff (PDF)

Relevance of carnosic acid to the treatment of several health disorders: Molecular targets and mechanisms

Biomedicine & pharmacotherapy, 2016-12, Vol.84, p.569-582

2016

Volltextzugriff (PDF)

Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate‐to‐severe plaque psoriasis

British journal of dermatology (1951), 2017-03, Vol.176 (3), p.752-758

2017

Volltextzugriff (PDF)

A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis

Experimental dermatology, 2018-06, Vol.27 (6), p.611-624

2018

Volltextzugriff (PDF)

A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis

British journal of dermatology (1951), 2015-09, Vol.173 (3), p.767-776

2015

Volltextzugriff (PDF)

Clinical pharmacokinetics and pharmacodynamics of topical non-biological therapies for psoriasis patients

Expert opinion on drug metabolism & toxicology, 2024-04, Vol.20 (4), p.235-248

2024

Volltextzugriff (PDF)

Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics

American journal of clinical dermatology, 2022-01, Vol.23 (1), p.83-91

2022

Volltextzugriff (PDF)

Evaluation of Potential Disease‐Mediated Drug–Drug Interaction in Patients With Moderate‐to‐Severe Atopic Dermatitis Receiving Dupilumab

Clinical pharmacology and therapeutics, 2018-12, Vol.104 (6), p.1146-1154

2018

Volltextzugriff (PDF)

Biocompatible polymer microneedle for topical/dermal delivery of tranexamic acid

Journal of controlled release, 2017-09, Vol.261, p.87-92

2017

Volltextzugriff (PDF)

Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study

British journal of dermatology (1951), 2016-05, Vol.174 (5), p.985-995

2016

Volltextzugriff (PDF)

Imaging and quantifying drug delivery in skin – Part 2: Fluorescence andvibrational spectroscopic imaging methods

Advanced drug delivery reviews, 2020-01, Vol.153, p.147-168

2020

Volltextzugriff (PDF)

Ixekizumab for the treatment of psoriasis: up-to-date

Expert opinion on biological therapy, 2020-06, Vol.20 (6), p.549-557

2020

Volltextzugriff (PDF)

1 – 25 von 469

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(413)
Mit Volltextzugriff
(363)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(398)
Life Sciences & Biomedicine
(386)
Humans
(357)
Dermatologic Agents - Pharmacokinetics
(352)
Dermatologic Agents - Administration & Dosage
(236)
Dermatology
(198)
Pharmacology & Pharmacy
(183)
Animals
(151)
Male
(128)
Biological And Medical Sciences
(127)
Female
(127)
Administration, Cutaneous
(126)
Medical Sciences
(126)
Dermatologic Agents - Therapeutic Use
(114)
Dermatologic Agents - Adverse Effects
(101)
Adult
(97)
Skin - Metabolism
(96)
Administration, Topical
(87)
Psoriasis - Drug Therapy
(87)
Skin Absorption
(80)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Dermatokinetics of Therapeutic Agents

Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: metabolism and bioactivities relevant to human health

The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects

Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial

Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box–Behnken design, in-vitro evaluation and in-vivo skin deposition study

Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products

A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis

Study of vitamin E microencapsulation and controlled release from chitosan/sodium lauryl ether sulfate microcapsules

Combination of argan oil and phospholipids for the development of an effective liposome-like formulation able to improve skin hydration and allantoin dermal delivery

Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents

Potential of Curcumin in Skin Disorders

Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis

Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula

Relevance of carnosic acid to the treatment of several health disorders: Molecular targets and mechanisms

Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate‐to‐severe plaque psoriasis

A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis

A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis

Clinical pharmacokinetics and pharmacodynamics of topical non-biological therapies for psoriasis patients

Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics

Evaluation of Potential Disease‐Mediated Drug–Drug Interaction in Patients With Moderate‐to‐Severe Atopic Dermatitis Receiving Dupilumab

Biocompatible polymer microneedle for topical/dermal delivery of tranexamic acid

Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study

Imaging and quantifying drug delivery in skin – Part 2: Fluorescence andvibrational spectroscopic imaging methods

Ixekizumab for the treatment of psoriasis: up-to-date

Suchergebnisse filtern